Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism

The androgen receptor (AR) plays a central role in prostate tumor growth. Inappropriate reactivation of the AR after androgen deprivation therapy promotes development of incurable castration-resistant prostate cancer (CRPC). In this study, we provide evidence that metabolic features of prostate canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Supriya, Carriveau, Whitney J., Li, Jinyang, Campbell, Sydney L., Kopinski, Piotr K., Lim, Hee-Woong, Daurio, Natalie, Trefely, Sophie, Won, Kyoung-Jae, Wallace, Douglas C., Koumenis, Constantinos, Mancuso, Anthony, Wellen, Kathryn E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190055/
https://www.ncbi.nlm.nih.gov/pubmed/27248322
http://dx.doi.org/10.18632/oncotarget.9666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190055/
https://www.ncbi.nlm.nih.gov/pubmed/27248322
http://dx.doi.org/10.18632/oncotarget.9666

Ejemplares similares